Home
Caligan Partners reported a 9.95% stake in Anika Therapeutics ANIK · 1,435,130 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 9.95%
- Last report
- 9.95% · filed 25/11/21
- Shares held
- 1,435,130 sh
- Class
- Common Stock, par value $0.01 per share
- Holder
- Caligan Partners
- Event date
- 26/01/23
- Filed
- 26/01/27
9.95% stake · +0.0pp from the last report
- Stake
- 9.95%
- Last report
- 9.95%
- Since last report
- +0.0pp
Anika Therapeutics trades, last 26 weeks
What else happened in Anika Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/24~02/22Caligan Partners's other 5% stake reports
- Caligan Partners
5% stakeSAB Biotherapeutics
5% stakeSAB Biotherapeutics
SABS
8.8% stake
7,967,207 sh
8.8% stake
Filed 08/14
- Caligan Partners
5% stakeAvalo Therapeutics
5% stakeAvalo Therapeutics
AVTX
5.9% stake
3,163,866 sh
5.9% stake
Filed 08/14
- Caligan Partners
5% stakeOpus Genetics
5% stakeOpus Genetics
IRD
7.3% stake
6,077,084 sh
7.3% stake
Filed 08/14
- Caligan Partners
5% stakeFaeth Therapeutics
5% stakeFaeth Therapeutics
FTH
2.4% stake
629,467 sh
2.4% stake
Filed 08/14
- Caligan Partners
5% stakeCellectar Biosciences
5% stakeCellectar Biosciences
CLRB
5.9% stake
469,998 sh
5.9% stake
Filed 08/14
